Louise Mohn (born 14 January 1974) is a Norwegian businesswoman who is the founder and chief executive officer of Luzmon Medical Technology.
After two years of investments in the UK, the pad prototype developed was unsuccessful, and Mohn decided to end her distribution agreement for the equipment.
[6] In 2008, Mohn was examined by doctors at Haukeland University Hospital, Bergen, after experiencing episodes with potential cardiac symptoms.
The medical team was positively surprised by her physical performance during the tests and her physique was primarily due to the result of cTEMS.
Mohn turned over documentation from 10 000 treatment sessions in London to a medical team at Haukeland University Hospital[7] who began designing a program of clinical trials.